CRDL
Cardiol Therapeutics
CRDL
CRDL
41 hedge funds and large institutions have $9.85M invested in Cardiol Therapeutics in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
9% less capital invested
Capital invested by funds: $10.8M → $9.85M (-$981K)
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
Holders
41
Holding in Top 10
–
Calls
$194K
Puts
$22K
Top Buyers
| 1 | +$226K | |
| 2 | +$97.1K | |
| 3 | +$72.1K | |
| 4 |
WANY
Wealthspire Advisors (New York)
New York
|
+$60K |
| 5 |
Two Sigma Investments
New York
|
+$48.8K |
Top Sellers
| 1 | -$586K | |
| 2 | -$254K | |
| 3 | -$202K | |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$109K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$80.9K |